Literature DB >> 21774787

Monoclonal antibodies reveal the alteration of the rhodocetin structure upon α2β1 integrin binding.

Thilo Bracht1, Flávia Figueiredo de Rezende, Jörg Stetefeld, Lydia M Sorokin, Johannes A Eble.   

Abstract

The α2β1 antagonist rhodocetin from Calloselasma rhodostoma is a heterotetrameric CLRP (C-type lectin-related protein) consisting of four distinct chains, α, β, γ and δ. Via their characteristic domain-swapping loops, the individual chains form two subunits, αβ and γδ. To distinguish the four chains which share similar molecular masses and high sequence homologies, we generated 11 mAbs (monoclonal antibodies) with different epitope specificities. Four groups of distinct mAbs were generated: the first targeted the rhodocetin β chain, the second group bound to the αβ subunit mostly in a conformation-dependent manner, the third group recognized the γδ subunit only when separated from the αβ subunit, whereas a fourth group interacted with the γδ subunit both in the heterotetrameric molecule and complexed with the integrin α2 A-domain. Using the specific mAbs, we have shown that the rhodocetin heterotetramer dissociates into the αβ and γδ subunit upon binding to the integrin α2 A-domain at both the molecular and cellular levels. After dissociation, the γδ subunit firmly interacts with the α2β1 integrin, thereby blocking it, whereas the rhodocetin αβ subunit is released from the complex. The small molecular interface between the αβ and γδ subunits within rhodocetin is mostly mediated by charged residues, which causes the two dissociated subunits to have hydrophilic surfaces.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774787     DOI: 10.1042/BJ20110584

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  6 in total

1.  Titration ELISA as a Method to Determine the Dissociation Constant of Receptor Ligand Interaction.

Authors:  Johannes A Eble
Journal:  J Vis Exp       Date:  2018-02-15       Impact factor: 1.355

2.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

Review 3.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

4.  Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively.

Authors:  Johannes A Eble; Matthew McDougall; George L Orriss; Stephan Niland; Benjamin Johanningmeier; Gottfried Pohlentz; Markus Meier; Simone Karrasch; Maria Inacia Estevão-Costa; Augusto Martins Lima; Jörg Stetefeld
Journal:  PLoS Biol       Date:  2017-07-13       Impact factor: 8.029

5.  Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models.

Authors:  Stephan Niland; Dorde Komljenovic; Jadranka Macas; Thilo Bracht; Tobias Bäuerle; Stefan Liebner; Johannes A Eble
Journal:  Oncotarget       Date:  2018-04-27

Review 6.  Structurally Robust and Functionally Highly Versatile-C-Type Lectin (-Related) Proteins in Snake Venoms.

Authors:  Johannes A Eble
Journal:  Toxins (Basel)       Date:  2019-03-01       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.